Annual CFO
-$194.92 M
-$16.77 M-9.42%
December 31, 2023
Summary
- As of February 7, 2025, RCKT annual cash flow from operations is -$194.92 million, with the most recent change of -$16.77 million (-9.42%) on December 31, 2023.
- During the last 3 years, RCKT annual CFO has fallen by -$120.28 million (-161.14%).
- RCKT annual CFO is now -2919.61% below its all-time high of -$6.46 million, reached on December 31, 2013.
Performance
RCKT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$52.10 M
+$1.72 M+3.20%
September 30, 2024
Summary
- As of February 7, 2025, RCKT quarterly cash flow from operations is -$52.10 million, with the most recent change of +$1.72 million (+3.20%) on September 30, 2024.
- Over the past year, RCKT quarterly CFO has increased by +$5.04 million (+8.83%).
- RCKT quarterly CFO is now -2708.79% below its all-time high of -$1.85 million, reached on March 31, 2014.
Performance
RCKT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$192.12 M
+$5.04 M+2.56%
September 30, 2024
Summary
- As of February 7, 2025, RCKT TTM cash flow from operations is -$192.12 million, with the most recent change of +$5.04 million (+2.56%) on September 30, 2024.
- Over the past year, RCKT TTM CFO has increased by +$29.48 million (+13.30%).
- RCKT TTM CFO is now -10256.93% below its all-time high of -$1.85 million, reached on March 31, 2014.
Performance
RCKT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RCKT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.4% | +8.8% | +13.3% |
| 3 y3 years | -161.1% | +8.8% | +13.3% |
| 5 y5 years | -262.4% | +8.8% | +13.3% |
RCKT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.9% | at low | -77.6% | +9.5% | -58.6% | +13.3% |
| 5 y | 5-year | -201.4% | at low | -297.5% | +9.5% | -197.1% | +13.3% |
| alltime | all time | -2919.6% | at low | -2708.8% | +9.5% | <-9999.0% | +13.3% |
Rocket Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$52.10 M(-3.2%) | -$192.12 M(-2.6%) |
| Jun 2024 | - | -$53.82 M(-5.3%) | -$197.17 M(+1.5%) |
| Mar 2024 | - | -$56.86 M(+93.8%) | -$194.21 M(-0.4%) |
| Dec 2023 | -$194.92 M(+9.4%) | -$29.34 M(-48.7%) | -$194.92 M(-12.0%) |
| Sep 2023 | - | -$57.15 M(+12.3%) | -$221.60 M(+6.4%) |
| Jun 2023 | - | -$50.87 M(-11.6%) | -$208.31 M(+6.0%) |
| Mar 2023 | - | -$57.56 M(+2.7%) | -$196.48 M(+10.3%) |
| Dec 2022 | -$178.14 M(+47.0%) | -$56.02 M(+27.7%) | -$178.14 M(+16.4%) |
| Sep 2022 | - | -$43.86 M(+12.3%) | -$153.06 M(+12.0%) |
| Jun 2022 | - | -$39.04 M(-0.5%) | -$136.62 M(+0.4%) |
| Mar 2022 | - | -$39.22 M(+26.8%) | -$136.10 M(+12.3%) |
| Dec 2021 | -$121.16 M(+62.3%) | -$30.94 M(+12.9%) | -$121.16 M(+17.3%) |
| Sep 2021 | - | -$27.41 M(-28.8%) | -$103.33 M(+10.9%) |
| Jun 2021 | - | -$38.53 M(+58.7%) | -$93.17 M(+21.5%) |
| Mar 2021 | - | -$24.28 M(+85.2%) | -$76.68 M(+2.7%) |
| Dec 2020 | -$74.64 M(+15.4%) | -$13.11 M(-24.0%) | -$74.64 M(-8.2%) |
| Sep 2020 | - | -$17.25 M(-21.7%) | -$81.26 M(+8.6%) |
| Jun 2020 | - | -$22.03 M(-1.0%) | -$74.86 M(+5.5%) |
| Mar 2020 | - | -$22.25 M(+12.7%) | -$70.93 M(+9.7%) |
| Dec 2019 | -$64.66 M | -$19.73 M(+81.9%) | -$64.66 M(-1.6%) |
| Sep 2019 | - | -$10.85 M(-40.1%) | -$65.74 M(-1.2%) |
| Jun 2019 | - | -$18.10 M(+13.3%) | -$66.53 M(+14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$15.98 M(-23.2%) | -$58.16 M(+8.1%) |
| Dec 2018 | -$53.79 M(+106.0%) | -$20.81 M(+78.9%) | -$53.79 M(+9.5%) |
| Sep 2018 | - | -$11.63 M(+19.5%) | -$49.11 M(+18.1%) |
| Jun 2018 | - | -$9.74 M(-16.1%) | -$41.57 M(+22.3%) |
| Mar 2018 | - | -$11.60 M(-28.1%) | -$33.99 M(+30.2%) |
| Dec 2017 | -$26.11 M(-29.9%) | -$16.14 M(+294.2%) | -$26.11 M(+23.7%) |
| Sep 2017 | - | -$4.09 M(+89.9%) | -$21.11 M(-19.3%) |
| Jun 2017 | - | -$2.16 M(-42.1%) | -$26.15 M(-18.3%) |
| Mar 2017 | - | -$3.72 M(-66.6%) | -$32.00 M(-14.1%) |
| Dec 2016 | -$37.27 M(+114.0%) | -$11.14 M(+22.0%) | -$37.27 M(+12.4%) |
| Sep 2016 | - | -$9.13 M(+14.1%) | -$33.17 M(+16.9%) |
| Jun 2016 | - | -$8.00 M(-11.0%) | -$28.36 M(+16.2%) |
| Mar 2016 | - | -$8.99 M(+27.8%) | -$24.42 M(+40.2%) |
| Dec 2015 | -$17.42 M(+78.8%) | -$7.04 M(+62.7%) | -$17.42 M(+30.3%) |
| Sep 2015 | - | -$4.33 M(+6.7%) | -$13.37 M(+12.5%) |
| Jun 2015 | - | -$4.06 M(+103.6%) | -$11.88 M(+20.2%) |
| Mar 2015 | - | -$1.99 M(-33.4%) | -$9.88 M(+1.4%) |
| Dec 2014 | -$9.74 M(+50.9%) | -$2.99 M(+5.5%) | -$9.74 M(+44.4%) |
| Sep 2014 | - | -$2.84 M(+37.9%) | -$6.75 M(+72.5%) |
| Jun 2014 | - | -$2.06 M(+10.9%) | -$3.91 M(+110.9%) |
| Mar 2014 | - | -$1.85 M | -$1.85 M |
| Dec 2013 | -$6.46 M(-6.9%) | - | - |
| Dec 2012 | -$6.94 M | - | - |
FAQ
- What is Rocket Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual CFO year-on-year change?
- What is Rocket Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly CFO year-on-year change?
- What is Rocket Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM CFO year-on-year change?
What is Rocket Pharmaceuticals annual cash flow from operations?
The current annual CFO of RCKT is -$194.92 M
What is the all time high annual CFO for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual cash flow from operations is -$6.46 M
What is Rocket Pharmaceuticals annual CFO year-on-year change?
Over the past year, RCKT annual cash flow from operations has changed by -$16.77 M (-9.42%)
What is Rocket Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of RCKT is -$52.10 M
What is the all time high quarterly CFO for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly cash flow from operations is -$1.85 M
What is Rocket Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, RCKT quarterly cash flow from operations has changed by +$5.04 M (+8.83%)
What is Rocket Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of RCKT is -$192.12 M
What is the all time high TTM CFO for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM cash flow from operations is -$1.85 M
What is Rocket Pharmaceuticals TTM CFO year-on-year change?
Over the past year, RCKT TTM cash flow from operations has changed by +$29.48 M (+13.30%)